The basic biology of apoptosis and its implications for cardiac function and viability

Annals of Thoracic Surgery

Volumn 75, Issue 2, 2003, Pages

  Valen, Guro ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL DAMAGE; CELL VIABILITY; CONFERENCE PAPER; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; HIBERNATION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; DNA FRAGMENTATION; HUMANS; IN SITU NICK-END LABELING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037317197     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)04687-8     Document Type: Conference Paper

References (47)

1. Mallat Z, Tedgui A. Current perspective on the role of apoptosis in atherothrombotic disease. Circ Res 2001;88:998-1003.
2. Bennet MR. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res 1999;41:361-8.
3. Kang PM, Izumo S. Apoptosis and heart failure. A critical review of the litterature. Circ Res 2000;86:1107-13.
4. Joza N, Susin SA, Daugas E, et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001;410:549-54.
5. Kruidering M, Evan GI. Caspase 8 in apoptosis: the beginning of "the end"? Life 2000;50:85-90.
6. Feuerstein GZ, Young PR. Apoptosis in cardiac disease: stress- and mitogen activated signalling pathways. Cardiovasc Res 2000;45:560-9.
7. Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 2000;45:528-37.
8. Eisässer A, Suzuki K, Schaper J. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Mol Cell Cardiol 2000;32:711-24.
9. Valen G, Yan Z-Q, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 2001;38:307-14.
10. Royston D. The inflammatory response and extracorporeal circulation. J Cardiothorac Vasc Anest 1997;11:341-54.
11. Vaage J, Valen G. Pathophyysiology and mediators of ischemia-reperfusion injury with special reference to cardiac surgery. Scand J Thorac Cardiovasc Surg 1993;41(Suppl):1-18.
12. Valen G, Vaage J. Toxic oxygen metabolites and leukocytes in reperfusion injury. Scand J Thorac Cardiovasc Surg 1993;41(Suppl):19-29.
13. Kawahito K, Misawa Y, Fuse K. Transient rise in serum soluble Fas (APO-1/CD95) in patients undergoing cardiac surgery. Artif Organs 2000;24:628.
14. Joashi U, Tibby SM, Turner C, et al. Soluble fas may be a proinflammatory marker after cardiopulmonary bypass in children. J Thorac Cardiovasc Surg 2002;123:137-44.
15. Cooper WA, Duarte IG, Thourani VH, et al. Hypothermic circulatory arrest causes multisystem vascular endothelial function and apoptosis. Ann Thorac Surg 2000;14:1953-64.
16. Aebert H, Kirchner S, Keyser A, et al. Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass. Eur J Cardiothorac Surg 2000;18:589-93.
17. Ning X-H, Chen S-H, Xu C-S, et al. Hypothermic protection of the ischaemic heart via alterations in apoptotic pathways as assessed by gene array analysis. J Appl Physiol 2002;92: 2200-7.
18. Chello M, Mastroroberto P, Quirino A, et al. Inhibition of neutrophii apoptosis after coronary bypass operation with cardiopulmonary bypass. Ann Thorac Surg 2002;73:123-9.
19. Valen G, Paulsson G, Vaage J. Induction of inflammatory mediators during reperfusion of the human heart. Ann Thorac Surg 2001;71:226-32.
20. Akao M, Ohler A, O'Rourke B, Marban E. Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ Res 2001;88:1267.
21. Knaapen MWM, Davies MJ, de Bie M, Haven AJ, Martinet W, Kockx M. Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res 2001;51:304-12.
22. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction. Cardiovasc Res 2000;45:630.
23. Elsasser A, Schlepper M, Klovekorn WP, et al. Hibernating myocardium: an incomplete adaption to ischemia. Circulation 1997;96:2920-31.
24. Aebert H, Cornelius T, Birnbaum DE, Siegel AV, Riegger GA, Schunkert H. Induction of early immediate genes and programmed cell death following cardiac arrest in human hearts. Eur J Cardiothorac Surg 1997;12:261-7.
25. Schmitt JP, Schroder J, Schunkert H, Birnbaum DE, Aebert H. Role of apoptosis in myocardial stunning after open heart surgery. Ann Thorac Surg 2002;73:1229-35.
26. Meldrum DR, Donnahoo KK. Role of TNF in mediating renal insufficiency following cardiac surgery: evidence of a postbypass syndrome. J Surg Res 1999;85:185-99.
27. Baumgartner WA, Walinsky PL, Salazar JD, et al. Assessing the impact of cerebral injury after cardiac surgery: will determining the mechanism reduce this injury? Ann Thorac Surg 1999;67:1871-3.
28. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94:11621-8.
29. Zhao ZQ, Velez DA, Wang NP, et al. Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 2001;6:279-90.
30. Wakiyama H, Cowan DB, Toyoda Y, Federman M, Levitsky S, McCully JD. Selective opening of mitochondrial ATP-sensitive potassium channels during surgically induced myocardial ischemia decreases necrosis and apoptosis. Eur J Cardiothorac Surg 2002;21:424-33.
31. Maulik N, Yoshida T. Oxidative stress developed during open heart surgery induces apoptosis: reduction of apoptotic cell death by ebselen, a glutathione peroxidase mimic. J Cardiovasc Pharmacol 2000;36:601-8.
32. Moudgil R, Menon R, Xu Y, Musat-Marcu S, Kumar D, Jugdutt BI. Postischemic apoptosis and functional recovery after angiotensin II type I receptor blockade in isolated working rat hearts. J Hypertens 2001;19:1121-9.
33. Weiland U, Haendeler J, Ihling C, et al. Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion induced myocardial apoptosis via a caspase 3 dependent pathway. Cardiovasc Res 2000;45:671-8.
34. Kovacs P, Bak I, Szendrei L, et al. Non-specific caspase inhibition reduces infarct size and improves postischemic recovery in isolated ischemic/reperfused rat hearts. Naunyn Schmiedebergs Arch Pharmacol 2001;364:501-7.
35. Condorelli G, Roncarati R, Ross J Jr, et al. Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function. Proc Natl Acad Sci USA 2001;98: 9977-82.
36. Chen Z, Chua CC, Ho YS, Hamdy RC, Chua BH. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial ischemia-reperfusion injury in transgenic mice. Am J Physiol 2001;280:H2313-20.
37. Ruetten H, Badorff C, Ihling C, Zeiher AM, Dimmeler S. Inhibition of caspase 3 improves contractile recovery of stunned myocardium, independent of apoptotsis inhibiting effects. J Am Coll Cardiol 2001;38:2063-70.
38. Masters TN, Fokin AA, Schaper J, et al. Extending myocardial viability during heart preservation with cyclosporine A. J Cardiac Surg 2000;15:392-402.
39. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
40. Tähepôld P, Valen G, Starkopf J, Karaine C, Zilmer M, Vaage J. Pretreating rats with hyperoxia attenuates ischaemia-reperfusion injury of the heart. Life Sci 2001;68:1629-40.
41. Gho BC, Schoemaker RG, Van den Doel MA, Duncker DJ, Verdouw PD. Myocardial protection by ischemia in noncardiac tissue. Circulation 1996;94:2193-200.
42. Tokuno S, Hinokiyama K, Tokuno K, Löwbeer C, Valen G. Spontaneous ischemic events in the heart and brain preconditions the hearts of severely atherosclerotic mice. Atheroscleros Thrombos Vasc Biol 2002;22:995-1001.
43. Stadler B, Phillips J, Toyoda Y, Federman M, Levitsky S, McCully JD. Adenosine-enhanced ischemic preconditioning modulates necrosis and apoptosis: effects of stunning and ischemia-reperfusion. Ann Thorac Surg 2001;72:555-63.
44. Maulik N, Goswami S, Galang N, Das DK. Differential regulation of Bcl-2, AP-1, and NFkB on cardiomyocyte apoptosis during myocardial ischemic stress adaption. FEBS Lett 1999;443:331-6.
45. Zhu L, Fukuda S, Cordis G, Das DK, Maulik N. Antiapoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hepoxic preconditioning. FEBS Lett 2001;508:369.
46. Liu H, Zhang HY, McPherson BC, et al. Role of opoid delta receptors, mitochondrial K(ATP) channels, and protein kinase C during cardiocyte apoptosis. J Mol Cell Cardiol 2001;33:2007-14.
47. Lin KM, Lin B, Lian IY, Mestril R, Scheffer IE, Dillmann WH. Combined and individual mitochondriai HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation 2001;103:1787-92.